Coordinating 11 Laboratories on His Own: How Is Cody Tranbarger Using Claude to Advance Rare Disease Research and Development?
“The most common perception of a ”one-person company” is that a single individual uses AI to write code, create designs, and handle sales. But when that company is researching drugs, the story cannot be understood solely in terms of miracles of efficiency. Experiments rely on real equipment and professionals, and conclusions must stand up to scrutiny; reducing the size of the organization does not eliminate scientific risks...